How Adult Stem Cell Therapy Is Breaking Glass Ceiling Of Modern Medicine – Leadership Newspapers
By daniellenierenberg
It offers hope for sufferers of diseases hitherto thought incurable
Adult Stem Cell Therapy has gained popularity in developed countries as an alternative to the conventional treatment of many diseases. There are several studies and clinical trials conducted in the United States to support this.
Some current line of treatments are not typically effective, and some can cause detrimental side effects. Medicine is evolving to a more natural and more effective means with the use of stem cells. Due to the numerous religious and ethical issues that comes with the use of embryonic stem cells, todays medicine is moving towards the application of Adult Stem Cell Therapy. This article highlights some new applications of adult stem cells in conditions and diseases that has posed a problem in our society for far too long.
Sickle Cell Anemia
Tissue-based treatments is already evident in the United States of America. In 2012, a patient was successfully cured of sickle cell disease after receiving achemotherapy-free stem cell transplant for sickle cell disease. Additional patients have been successfully treated since then. Two studies conducted in 2014 and 2015 have shown that the use of adult stem cell therapy can greatly reduce complications or even stop the progression of the diseases by providing stem cells to the needed areas. This reduces the need for surgeries for many of these patients.
Diabetes
According to International Diabetes Federation (IDF), there were over 40,000 deaths due to diabetes documented in Nigeria in 2015. Treatment for diabetes has been a focal point for medical research for many years. Consequently, some studies and clinical trials conducted have shown that Adult Adipose (fat) Stem Cell Transplantation can lower and regulate sugar levels resulting in reducing or eliminating the amount of medication or insulin that patients need to take.
In a recently conducted clinical trial, some of the patients achieved insulin independence that remained stable for a median time of 29 months, and another patient for 43 months ongoing. In fact, all the patients studied showed substantial improvement in their dependence on insulin and overall diabetic condition.
Sexual Dysfunction
The emergence of Regenerative Medicine (which includes Adult Stem Cell and Platelet Rich Plasma therapy) has positively impacted the sexual life of both women (O-Shot) and men (P-Shot), and the treatment is also being used for urinary incontinence, etc. There is now ample evidence to show that O-Shot helps women increase their sexual responses, the ability to have Vaginal Orgasm, arousal from clitoral stimulation, sexual desire and natural lubrication, arousal from G-spot stimulation, as well as decrease pain during intercourse and tighten vaginal opening.
Furthermore, P-Shotin men regenerates damaged penile tissues faster and stronger than most traditional treatments. In most cases, treated men see increase in length up to 1 inch or more and girth up to 3/4 inch or more while also increasing their sexual stamina.
Arthritis
Adult stem cells transplantationhas also been studied in arthritis, and there has been some positive reports about its efficacy. In 2014, the effects of stem cells for articular cartilage regeneration was studied.They studied the effect of stem cells injection in treating osteoarthritis of the knee, and the results showed significant improvement.
Neurological Disorders (e.g. Spinal Cord Injury)
The usefulness of stem cell therapy in neurological disorders like Multiple Sclerosis, Cerebral Palsy, Spinal Cord Injury, etc. has been shown in different studies and clinical trials. The prognosis for spinal cord injuries is generally believed to be poor. However, recent researches and case studies are changing this ideology as the value of adult stem cell therapy for patients with spinal cord injuries is emerging.
An example of this can be seen in a case study published in 2015. In this case study, a patient with functional loss below the lesion level due to a motor vehicle accident failed standard therapy but saw clinically meaningful improvements after multiple adult stem cell treatments. Stem cell transplantations over a period of months led to the restoration of the patients ability to move lower extremities against gravity, control the body trunk, and the ability to control the bladder. The patient was also able to stand as well as walk with the aid of hip and knee ortheses. The sensation level also increased.
Conclusion
Regenerative medicine involving adult stem cells is continually being studied and researched to gather more evidence to enable harnessing its clinical potentials. The use of adult stem cells for clinical therapy is now a reality for many patients who were not able to shed the yoke of many diseases that conventional medicine provided very little hope of permanent relief for.
One new innovation is the Umbilical Cord Stem Cells transplantation that is now done without the need for HLA matching. This allows anyone to be treated for conditions or diseases where applicable. In case of sickle cell disease, case studies have been published on the use of Umbilical Cord Stem Cells from HLA matching donors to remedy sickle cell disease; however, case studies are yet to be published on the efficacy of the Umbilical Cord Stem Cells not requiring HLA matching for the treatment of sickle cell disease. I am cautious to note that the results may differ from case to case, so not every sickle cell patient will be a good candidate for the treatment.
Currently, Adult Stem Cell Therapy is now seen as a viable therapeutic alternative for joint and back pain, sexual dysfunction, diabetes, End Stage Renal Disease on hemodialysis, arthritis, etc. The treatments are gaining popularity among patients and doctors because it is natural and can help repair and regenerate most parts of the human tissues.
Ikudaiyisi is the Medical Director of Glory Wellness and Regenerative Centre in USA, Lagos and Abuja and can be reached on info@glorywellness.org
Excerpt from:
How Adult Stem Cell Therapy Is Breaking Glass Ceiling Of Modern Medicine - Leadership Newspapers
- Much-anticipated human trial aiming to repair spinal cord damage about to begin - ABC News - October 21st, 2024
- The Science Of Health: Are Spinal Cord Injuries Irreversible? Know Science Advances That Can Cure Them In The Future - ABP Live - October 16th, 2023
- Evaluating the Growth Prospects of the Global Nerve Repair & Regeneration Market at a CAGR of 6.5% | Emergen - EIN News - April 21st, 2023
- Regenerative Therapies Market is Set to Grow at a CAGR of 8.7% by 2033, Propelled by Advancements in - EIN News - March 17th, 2023
- Kadimastem Submits IND Application to the FDA for its Phase IIa Clinical Trial with AstroRx for the Treatment of ALS - Marketscreener.com - February 21st, 2023
- My Back Is All F*cked Up 55-Year-Old Joe Rogan Curses at Worst Jiu-Jitsu for Painful Health Condition - EssentiallySports - February 21st, 2023
- Brain and Spinal Cord Tumors: Hope Through Research - January 3rd, 2023
- 14.3 The Brain and Spinal Cord Anatomy & Physiology - January 3rd, 2023
- Stem Cell Therapy for Spinal Cord Injury - PubMed - January 3rd, 2023
- Spinal cord injury - Diagnosis and treatment - Mayo Clinic - December 25th, 2022
- Spinal Cord Injury: Hope Through Research | National Institute of ... - December 1st, 2022
- Stem cell controversy - Wikipedia - October 13th, 2022
- Stem Cells Australia | Australian research, stem cell treatments and ... - October 13th, 2022
- The eye and stem cells: the path to treating blindness - October 13th, 2022
- World's first stem cell treatment for spina bifida delivered during fetal surgery - UC Davis Health - October 13th, 2022
- Fighting One Disease or Condition per Day - Daily Kos - October 13th, 2022
- UPDATE: NurExone Signs Letter of Intent with Nanometrix for Its Exosome and Cargo Molecular Profiling AI-Driven Technology - Yahoo Finance - October 13th, 2022
- Global Cell Therapy Market Report (2022 to 2028) - Featuring Thermo Fisher Scientific, MaxCyte, Danaher and Avantor Among Others -... - October 13th, 2022
- Horizon Therapeutics plc Announces New UPLIZNA (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS... - October 13th, 2022
- Physiology, Spinal Cord - StatPearls - NCBI Bookshelf - October 5th, 2022
- IMAC Holdings, Inc. Announces Completion of Third Cohort of its Phase 1 ... - October 5th, 2022
- Revolutionary Jab that Could Repair Spinal Cord Injuries Developed by Scientists - Good News Network - October 5th, 2022
- How the 'Love Hormone' Oxytocin May Help Heal Heart Muscles - Healthline - October 5th, 2022
- Unlocking the Mysteries of Brain Regeneration Groundbreaking Study Offers New Insight - SciTechDaily - October 5th, 2022
- In Conversation: How to understand chronic pain - Medical News Today - October 5th, 2022
- New drug could cure aggressive brain cancer stopping tumours in their tracks... - The US Sun - September 27th, 2022
- Rehabilitating spinal cord injury and stroke with graphene and gaming - Nanowerk - September 19th, 2022
- Induced Pluripotent Stem Cells Market Reaches at a CAGR of 8.0% in the Forecast Periods [2021-2031] - BioSpace - September 19th, 2022
- Axolotls can regenerate their brains - Big Think - September 19th, 2022
- IMAC Holdings, Inc. Announces Completion of Third Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the... - September 11th, 2022
- Spinal Muscular Atrophy: Causes and importance of early diagnosis for proactive management - Firstpost - September 11th, 2022
- Increasing Road Accidents and Fall Injuries among Aged Population Primarily Driving Need for Orthopedic Navigation Systems: Fact.MR Analysis - Yahoo... - September 3rd, 2022
- Culture of human nasal olfactory stem cells and their extracellular vesicles as advanced therapy medicinal products - Newswise - August 10th, 2022
- Curious kids: what is inside teeth? - The Conversation - August 10th, 2022
- Human placental mesenchymal stem cells derived exosomes improved functional recovery via attenuating apoptosis and increasing axonal regeneration... - August 2nd, 2022
- How the Regenerative Properties of Glioblastoma Can Be Terminated - Gilmore Health News - August 2nd, 2022
- New TSXV listing looks to address the $3B spinal cord injury treatment market (NRX.V) - FXStreet - July 25th, 2022
- Human iPSC co-culture model to investigate the interaction between microglia and motor neurons | Scientific Reports - Nature.com - July 25th, 2022
- Negligence in treatment of diseases like glioblastoma can be fatal, seminar told - The News International - July 25th, 2022
- What lab-grown cerebral organoids are revealing about the brain - New Scientist - July 25th, 2022
- Innovative Therapies, Care Equity Highlight 2022 ASCO Annual Meeting - Targeted Oncology - July 16th, 2022
- Global Stem Cell Manufacturing Market Value Projected To Reach USD 21.71 Billion By 2029, Registering A CAGR Of 9.1% - Digital Journal - July 16th, 2022
- Stem Cell Therapy Market Is Expected To Reach USD 455.61 Billion By 2027 At A CAGR Of 16 percent By Forecast 2027 Says Maximize Market Research (MMR)... - June 30th, 2022
- This startup wants you to have a personal stem cell stash - Freethink - June 30th, 2022
- Parents of 12-Year-Old Boy Praying for a Miracle, Appealing UK Judge's Decision to Remove Life Support - CBN.com - June 30th, 2022
- The end of Roe v. Wade affects more than just abortion - Vox.com - June 30th, 2022
- Horizon Therapeutics plc Submits Regulatory Filing for UPLIZNA (inebilizumab) in Brazil - Business Wire - June 20th, 2022
- Effect of Electrical Stimulation on Spinal Cord Injury: In Vitro and In Vivo Analysis - Newswise - June 11th, 2022
- First-of-its-Kind Stem Cell and Gene Therapy Highlighted at Annual Stem Cell Meeting - Newswise - June 11th, 2022
- UK Judge to Decide if 12-Year-Old Will Be Removed from Life Support, Parents Beg for More Time to Heal - CBN.com - June 11th, 2022
- 'This is my life, and I'll try anything to save it': Woman with MS raising funds for treatment - The Brandon Sun - May 29th, 2022
- Racing Thoughts: Quadriplegic Man Drives Race Car With His Brain - Newsy - May 29th, 2022
- Physical therapy for vertigo: Exercises, benefits, and more - Medical News Today - May 29th, 2022
- Researchers find new function performed by almost half of brain cells - Medical News Today - May 13th, 2022
- Texas Family Fights to Access $2.1 Million Treatment for Baby - NBC 5 Dallas-Fort Worth - May 13th, 2022
- Severe COVID-19 may cause cognitive deficits equivalent to 20 years of aging - Medical News Today - May 13th, 2022
- Stem Cell Magic: 5 Promising Treatments For Major Medical Conditions - Study Finds - April 29th, 2022
- Neural Stem Cell Therapy For Spinal Cord Injury To Tap Into The Potential Of Stem Cells - Optic Flux - April 15th, 2022
- Still Blooming: Sams mission to raise money for spinal cord injury research - 7NEWS - April 15th, 2022
- Lineage and Cancer Research UK Announce Completion of Patient Enrollment in Phase 1 Clinical Study of VAC2 for the Treatment of Non-small Cell Lung... - April 15th, 2022
- Lineage Announces Pipeline Expansion to Include Auditory Neuronal Cell Therapy for Treatment of Hearing Loss - Galveston County Daily News - March 22nd, 2022
- COVID-19: Even mild to moderate infection may cause brain anomalies - Medical News Today - March 22nd, 2022
- Scots mum with MS says 50k treatment abroad is 'last hope' of halting disease - Daily Record - January 18th, 2022
- Mending the gap: U of T's Molly Shoichet joins team developing new treatments for spinal cord injuries - News@UofT - January 18th, 2022
- Spinal Cord Injury Information Page | National Institute ... - January 3rd, 2022
- Dancing molecules successfully repair severe spinal cord ... - January 3rd, 2022
- Best 2021 Medical Breakthroughs And Treatments to Beat Cancer, Alzheimer's, Diabetes & More - Good News Network - January 3rd, 2022
- Global Regenerative Medicine Market is Expected to Reach USD 57.08 Billion by 2027, Growing at a CAGR of 11.27% Over the Forecast Period. -... - December 23rd, 2021
- Scientists unravel a gene function that helps the genesis of neurons - Research Matters - December 23rd, 2021
- The 10 Most Compelling Research Stories of 2021 PharmaLive - PharmaLive - December 23rd, 2021
- 2021: The year in review | YaleNews - Yale News - December 23rd, 2021
- Polymyositis Pipeline to Progress with New and Emerging Drugs for Treatment, Analyzes DelveInsight - GlobeNewswire - December 10th, 2021
- Cell and Gene Therapy Market to reach US$ 47,095.2 Mn by end of 2028, Says Coherent Market Insights - PRNewswire - November 22nd, 2021
- From asthma to cancer to infertility, the new treatments, jabs and meds making us healthier... - The Sun - November 22nd, 2021
- Improving motor neuron-like cell differentiation of hEnSCs by the combination of epothilone B loaded PCL microspheres in optimized 3D collagen... - November 8th, 2021
- Akiko Nishiyama Explains the Many Strengths of a Degree in Physiology and Neurobiology - UConn Today - UConn Today - October 28th, 2021
- Team finds way to enhance stem cell therapy for CNS injuries - BioPharma-Reporter.com - October 28th, 2021
- 'Rogue' antibodies found in brains of teens with delusions and paranoia after COVID-19 - Livescience.com - October 28th, 2021
- Traumatic Spinal Cord Injury: An Overview of ... - October 16th, 2021
- Role of Stem Cells in Treatment of Neurological Disorder - October 16th, 2021